Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Breast Cancer Research

Fig. 2

From: Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes

Fig. 2

Expression of the lymphocyte markers and PIK3CA mutation status. a Forest plot graphically represents the magnitude of the association between each pathological feature and PIK3CA mutation status, calculated by multivariable logistic regression model (as complete case analysis). b Distribution of CD8 expression according to PIK3CA mutation status in all tumors and c within grade 1 or 2 tumors. Statistical differences between the expression means among the two categories were calculated by t test: p(t). Abbreviation: pN0 lymph node negative, pN1+ lymph node positive, PR progesterone receptor

Back to article page